Detalhe da pesquisa
1.
Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer.
Acta Oncol
; 60(2): 157-164, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259244
2.
The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer.
Future Oncol
; 15(22): 2561-2569, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31215242
3.
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study.
Breast Cancer Res Treat
; 172(2): 391-400, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30099635
4.
Efficacy and toxicity of eribulin treatment in metastatic breast cancer patients.
Acta Oncol
; 58(1): 119-121, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30101626
5.
[Isoflavones have therapeutic efficacy inoestrogen deficiency].
Ugeskr Laeger
; 182(21)2020 05 18.
Artigo
em Dinamarquês
| MEDLINE | ID: mdl-32515321
6.
Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay.
Breast Cancer
; 27(2): 266-276, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31654283
7.
Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer.
Acta Oncol
; 53(9): 1275-7, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24844919
8.
Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting.
Clin Chem Lab Med
; 47(9): 1117-23, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19728854
9.
[Prevention of skeletal related events in patients with bone metastases from solid tumours]. / Forebyggelse af skeletrelaterede hændelser hos patienter med knoglemetastaser ved solide tumorer.
Ugeskr Laeger
; 176(8A): V08130525, 2014 Feb 17.
Artigo
em Dinamarquês
| MEDLINE | ID: mdl-25350304
10.
Treatment and treatment considerations in a patient with advanced breast cancer and acute intermittent porphyria.
Acta Oncol
; 45(3): 337-9, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16644579